1. Home
  2. FARO vs DCTH Comparison

FARO vs DCTH Comparison

Compare FARO & DCTH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • FARO
  • DCTH
  • Stock Information
  • Founded
  • FARO 1981
  • DCTH 1988
  • Country
  • FARO United States
  • DCTH United States
  • Employees
  • FARO N/A
  • DCTH N/A
  • Industry
  • FARO Industrial Machinery/Components
  • DCTH Medical/Dental Instruments
  • Sector
  • FARO Industrials
  • DCTH Health Care
  • Exchange
  • FARO Nasdaq
  • DCTH Nasdaq
  • Market Cap
  • FARO 808.5M
  • DCTH 630.4M
  • IPO Year
  • FARO 1997
  • DCTH N/A
  • Fundamental
  • Price
  • FARO $42.37
  • DCTH $16.21
  • Analyst Decision
  • FARO Buy
  • DCTH Strong Buy
  • Analyst Count
  • FARO 2
  • DCTH 4
  • Target Price
  • FARO $35.50
  • DCTH $24.00
  • AVG Volume (30 Days)
  • FARO 1.5M
  • DCTH 610.5K
  • Earning Date
  • FARO 04-24-2025
  • DCTH 05-08-2025
  • Dividend Yield
  • FARO N/A
  • DCTH N/A
  • EPS Growth
  • FARO N/A
  • DCTH N/A
  • EPS
  • FARO N/A
  • DCTH N/A
  • Revenue
  • FARO $341,046,000.00
  • DCTH $53,850,000.00
  • Revenue This Year
  • FARO $3.49
  • DCTH $141.47
  • Revenue Next Year
  • FARO $5.72
  • DCTH $49.31
  • P/E Ratio
  • FARO N/A
  • DCTH N/A
  • Revenue Growth
  • FARO N/A
  • DCTH 1068.87
  • 52 Week Low
  • FARO $13.52
  • DCTH $6.33
  • 52 Week High
  • FARO $42.64
  • DCTH $18.23
  • Technical
  • Relative Strength Index (RSI)
  • FARO 78.62
  • DCTH 58.15
  • Support Level
  • FARO $41.96
  • DCTH $16.02
  • Resistance Level
  • FARO $42.22
  • DCTH $17.29
  • Average True Range (ATR)
  • FARO 0.24
  • DCTH 0.99
  • MACD
  • FARO -0.41
  • DCTH -0.03
  • Stochastic Oscillator
  • FARO 60.29
  • DCTH 49.63

About FARO FARO Technologies Inc.

Faro Technologies Inc is a technology company. It designs, develops, manufactures, markets and supports software-driven, three-dimensional (3-D) measurement, imaging, and realization solutions for the 3D metrology, architecture, engineering and construction (AEC), Operations and Maintenance (O&M) and public safety analytics markets. The company enables its customers to capture, measure, manipulate, interact with and share 3D and 2D data from the physical world in a virtual environment and then translate the information back into the physical domain. FARO suite of 3D products and software solutions are used for the inspection of components and assemblies, rapid prototyping, reverse engineering, documenting large volumes or structures in 3D, surveying, and construction.

About DCTH Delcath Systems Inc.

Delcath Systems Inc is an oncology company. It is focused on the treatment of primary and metastatic liver cancers. The firm's product, Melphalan Hydrochloride for Injection along with the Delcath Hepatic Delivery System, or Melphalan/HDS, is a drug and device combination product, designed to administer high-dose chemotherapy to the liver while controlling systemic exposure and associated side effects. The company operates in one reportable segment which includes the research, development, manufacture, and distribution of hepatic delivery systems for use in the treatment of specific conditions. The Company operates its business in the United States and Europe.

Share on Social Networks: